• Topics

  • Formats

Organiser: Pharmaphorum

The silent killer of pharma brands isn't competition – it's complacency. As your product's growth curve flattens and sales targets remain stubbornly out of reach, the temptation to double down on familiar strategies becomes nearly irresistible. Meanwhile, procurement's drumbeat for cost reduction grows louder, demanding justification for every marketing penny spent.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?